Lipoprotein
发表于 2025-3-25 06:54:21
http://image.papertrans.cn/r/image/824548.jpg
障碍物
发表于 2025-3-25 11:31:25
https://doi.org/10.1007/978-3-319-17515-7Acute respiratory distress syndrome; Democratic-based medicine; Emergency medicine; Intensive care; Seps
Fresco
发表于 2025-3-25 14:57:50
Giovanni Landoni,Marta Mucchetti,Rinaldo BellomoIdentifies the techniques, strategies, and drugs proven by multi center randomized trials to influence survival in critically ill patients.Focuses on a specific procedure, device, or drug in each chap
motor-unit
发表于 2025-3-25 19:48:41
http://reply.papertrans.cn/83/8246/824548/824548_24.png
粘
发表于 2025-3-25 21:29:55
http://reply.papertrans.cn/83/8246/824548/824548_25.png
不能强迫我
发表于 2025-3-26 04:07:43
978-3-319-36726-2Springer International Publishing Switzerland 2015
strain
发表于 2025-3-26 08:14:13
http://reply.papertrans.cn/83/8246/824548/824548_27.png
老人病学
发表于 2025-3-26 10:03:37
http://reply.papertrans.cn/83/8246/824548/824548_28.png
BET
发表于 2025-3-26 13:36:36
Daily Interruption of Sedatives to Improve Outcomes in Critically Ill Patientsrm mortality (one year) in critically ill patients receiving daily sedation interruption and spontaneous breathing trial. The positive effect on survival was not reproduced by a further trial where daily interruption of sedative. However, in this study, the intervention group received significantly more sedatives than the control group.
sulcus
发表于 2025-3-26 19:59:09
Hydroxyethyl Starch in Critically Ill Patients or carrier fluid influence trial results. Further, the beneficial effects of HES appear negligible - if present at all - and HES products - in any formulation - are therefore not to be used in critically ill patients.